Back to Stakeholders
Grant-Making OrganizationsPsychedelic-Specific Foundations

Fox (Michael J.) Foundation for Parkinson's Research

United States
2 Trials

The Michael J. Fox Foundation for Parkinson's Research (MJFF) is a New York-based non-profit founded in 2000 by actor Michael J. Fox that has raised over $2 billion for Parkinson's disease research and treatments. MJFF has funded pioneering psychedelic research including the first psilocybin trial in a neurodegenerative disease (UCSF/Yale, for Parkinson's-related depression) and a ketamine infusion trial at Yale for treatment-resistant depression in Parkinson's patients.

Quick Facts

Type
Non-Profit
HQ
United States
Website
Visit

Collaborated Trials

2
Enrolling by invitationNA

Long Term Follow Up KET-PD

Start Date
Compounds
Ketamine, Placebo
CompletedII

Ketamine for the Treatment of Depression in Parkinson's Disease

Start Date
Compounds
Ketamine, Placebo